DCC Gene Product in Colorectal Cancer
Author Information
Author(s): CA Schmitt, KR Thaler, BM Wittig, H Kaulen, K-H Meyer zum Buschenfeldel, WG Dippold
Primary Institution: Johannes-Gutenberg-University, Mainz, Germany
Hypothesis
The study aims to evaluate the expression of the DCC gene product in colorectal cancer and its relationship with genetic mutations.
Conclusion
DCC protein expression is significantly lost in colorectal cancer tissues compared to normal tissues, indicating its potential role as a prognostic marker.
Supporting Evidence
- 75% of the cases showed informative results regarding loss of heterozygosity.
- DCC mRNA was detected in all normal tissues but in only 40% of tumors.
- DCC protein expression was absent in 69% of tumor samples.
Takeaway
This study looked at how a specific gene related to cancer behaves in healthy and cancerous tissues, finding that the cancerous tissues often lack this gene's protein.
Methodology
The study used matched colorectal cancer and normal tissue samples to analyze DCC protein and mRNA expression through immunohistochemistry and RT-PCR.
Limitations
The study may underestimate the frequencies of LOH or lost mRNA expression due to potential contamination of tumor specimens with normal colonic mucosa cells.
Participant Demographics
Patients with colorectal cancer from Mainz, Germany.
Want to read the original?
Access the complete publication on the publisher's website